Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 449

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update

Open access
Lehrnbecher, Thomas, Robinson, Paula, Fisher, Brian, Alexander, Sarah, Ammann, Roland A., Beauchemin, Melissa, Carlesse, Fabianne, Groll, Andreas H., Haeusler, Gabrielle M., Santolaya, Maria, Steinbach, William J., Castagnola, Elio, Davis, Bonnie L., Dupuis, L. Lee, Gaur, Aditya H., Tissing, Wim J.E., Zaoutis, Theo, Phillips, Robert, Sung, Lillian·2017·Journal of Clinical Oncology

Abstract

Purpose: To update a clinical practice guideline (CPG) for the empirical management of fever and neutropenia (FN) in children with cancer and hematopoietic stem-cell transplantation recipients. Methods: The International Pediatric Fever and Neutropenia Guideline Panel is a multidisciplinary and multinational group of experts in pediatric oncology and infectious diseases that includes a patient advocate. For questions of risk stratification and evaluation, we updated systematic reviews of observational studies. For questions of therapy, we conducted a systematic review of randomized trials of any intervention applied for the empirical management of pediatric FN. The Grading of Recommendation Assessment, Development and Evaluation approach was used to make strong or weak recommendations and to classify levels of evidence as high, moderate, low, or very low. Results: Recommendations related to initial presentation, ongoing management, and empirical antifungal therapy of pediatric FN were reviewed; the most substantial changes were related to empirical antifungal therapy. Key differences from our 2012 FN CPG included the listing of a fourth-generation cephalosporin for empirical therapy in high-risk FN, refinement of risk stratification to define patients with high-risk invasive fungal disease (IFD), changes in recommended biomarkers and radiologic investigations for the evaluation of IFD in prolonged FN, and a weak recommendation to withhold empirical antifungal therapy in IFD low-risk patients with prolonged FN. Conclusion: Changes to the updated FN CPG recommendations will likely influence the care of pediatric patients with cancer and those undergoing hematopoietic stem-cell transplantation. Future work should focus on closing research gaps and on identifying ways to facilitate implementation and adaptation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2016.71.7017

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 78 references

Cited by

See all 449

Metadata

Authors
Lehrnbecher, T., Robinson, P., Fisher, B., Alexander, S., Ammann, R. A., Beauchemin, M., Carlesse, F., Groll, A. H., Haeusler, G. M., Santolaya, M., Steinbach, W. J., Castagnola, E., Davis, B. L., Dupuis, L. L., Gaur, A. H., Tissing, W. J. E., Zaoutis, T., Phillips, R., & Sung, L.
Venue
Journal of Clinical Oncology
Published
2017-06-20
Volume
35
Issue
18
Pages
2082-2094
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2610889635
Cited by
449
References
78
FWCI
16.26
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. https://app.cochat.ai/papers/10.1200/jco.2016.71.7017
The paper
Lehrnbecher, T., Robinson, P., Fisher, B., Alexander, S., Ammann, R. A., Beauchemin, M., Carlesse, F., Groll, A. H., Haeusler, G. M., Santolaya, M., Steinbach, W. J., Castagnola, E., Davis, B. L., Dupuis, L. L., Gaur, A. H., Tissing, W. J. E., Zaoutis, T., Phillips, R., & Sung, L. (2017). Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2016.71.7017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.